Even Capital has invested in New Zealand-based Daisy Lab, a precision fermentation start-up, to accelerate its innovative approach to sustainable protein production.

Information on the Target

Daisy Lab is an innovative precision fermentation start-up based in New Zealand, recognized for its pioneering efforts in the food technology sector. Founded by a trio of accomplished female entrepreneurs, Daisy Lab is focused on creating sustainable solutions to address significant global issues such as climate change and food insecurity.

The company leverages advanced microbial technology to produce high-quality proteins and various biomolecules. This approach not only aims to fulfill growing protein demands but also seeks to minimize greenhouse gas emissions and reduce the consumption of land and water resources, presenting a more humane alternative to traditional animal farming.

Industry Overview in New Zealand

The food technology industry in New Zealand is rapidly evolving, driven by increasing consumer awareness regarding health, sustainability, and ethical production practices

View Source

Similar Deals

Movac Avasa

2025

Seed Stage Medical Devices & Implants New Zealand
GD1 Formus Labs

2023

Seed Stage Medical Software & Technology Services New Zealand
Pacific Channel CertusBio

2023

Seed Stage Biotechnology & Medical Research (NEC) New Zealand
Pacific Channel Upstream Medical Technologies

2023

Seed Stage Medical Diagnostic & Testing Equipment New Zealand
Blackbird NZ Fund Carepatron

2023

Seed Stage Telemedicine Services New Zealand
NZVC Bovonic

2023

Seed Stage Bio Medical Devices New Zealand

Even Capital

invested in

Daisy Lab

in

in a Seed Stage deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert